Online inquiry

IVTScrip™ mRNA-Human AKIRIN2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK20470MR)

This product GTTS-WK20470MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methoxy-UTP. It ecodes the AKIRIN2 protein. This product can be used in Regulatory T (Treg) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methoxy-UTP
5' Cap Cap 1
Species Human
RefSeq NM_018064.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 55122
UniProt ID Q53H80
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AKIRIN2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) (GTTS-WK20470MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK21703MR IVTScrip™ mRNA-Human ARHGAP9, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP9
GTTS-WK17303MR IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK21538MR IVTScrip™ mRNA-Human ANKS3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKS3
GTTS-WK12799MR IVTScrip™ mRNA-Human ADAMTS14, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS14
GTTS-WK11932MR IVTScrip™ mRNA-Human ADGRB1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRB1
GTTS-WK21536MR IVTScrip™ mRNA-Human ANKRD7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD7
GTTS-WK17309MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK9530MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →